• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Keane

Keane

  1. All
  2. 3rd Party
  3. Investing
  1. Mauna Kea Technologies: New Publication Confirms Benefits of Using Cellvizio for Characterizing Upper Urinary Tract Cancer

    Mauna Kea Technologies: New Publication Confirms Benefits of Using Cellvizio for Characterizing Upper Urinary Tract Cancer

  2. Mauna Kea Technologies to Present at the JMP Securities 2017 Life Sciences Conference

    Mauna Kea Technologies to Present at the JMP Securities 2017 Life Sciences Conference

  3. So Long, Scudder

    Plus, changes at Federated, Loomis Sayles, and more.

1

©2017 Morningstar Advisor. All right reserved.